This study was a combination of Quality Improvement (QI) and practice-based research activities. By having members of each practice utilize quality improvement tools, we tested strategies for making and sustaining improved depression care. This also allowed us to assess the clinical utility of simple quantitative instruments (i.e., PHQ-9) that measure the severity of depression.
Our specific aims were:
This study was conducted from October 1, 2004, through March 31, 2006.
This project has been completed. Please see below for Key Findings and Publications.
For additional information about this study, please contact:
Debbie Graham, MSPH
AAFP National Research Network
The program led to measurable improvements in implementation of office procedures and systems known to improve depression care. The improvements were both sustained beyond the end of the program and substantially diffused to the other clinicians in the practice.
Access the complete manuscript:
Integrating Practice Change Processes into Quality Improvement of Depression Care: A report from the National Depression Management Leadership Initiative’s Improving Depression(9 page PDF) Care project. Main DS, Graham DG, Nutting PA, et al. Jt Comm J Qual Patient Saf 2009;35(7):351-357
It Takes Two: Using Co-Leaders to Champion Improvements in Small Primary Care Practices.(8 page PDF) Gallagher KM, Nutting PA, Nease DE, et al. J Am Board Fam Med. 2010;23(5):632-639.
Systematic Use of Patient-Rated Depression Severity Monitoring: Is It Helpful and Feasible in Clinical Psychiatry?(7 page PDF) Duffy FF, Chung H, Trivedi M, et al. Psych Serv. 2008;59:1148-1154.
Inducing Sustainable Improvement in Depression Care in Primary Care Practices: A Report from the National Depression Management Leadership Initiative's Improving Depression Care Project(9 page PDF).(9 page PDF) Nease DE, Nutting PA, Dickinson WP, et al. Jt Comm J Qual Patient Saf 2008;34(5):247-255.
This project was funded by grants from AstraZeneca International, Eli Lilly and Company, Lilly Foundation, Forest Laboratories, Inc., Pfizer Inc., Sanofi Aventis, and Wyeth.
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.
Improving Depression Care - National Depression Management Leadership Initiative